NR1D2 and glioblastoma: To verify whether NR1D2 could directly bind to the promoter regions of Hippo and Notch target genes, we performed chromatin immunoprecipitation (ChIP) assays in GSCs and GBM cells that stably expressed HA-tagged NR1D2 (HA-NR1D2).